Quatrefolic® is supported by a growing body of scientific research:
A recent double-blind, randomized controlled trial conducted in Indonesia compared 5-MTHF glucosamine salt supplementation with conventional folic acid in pregnant women.
The 12-week study provides relevant evidence on folate bioavailability and metabolic responses during pregnancy, reinforcing Quatrefolic®'s scientific premium position as an alternative folate source for prenatal supplementation.
Quatrefolic® is a premium, glucosamine salt form of 5-MTHF, designed to provide folate in its biologically active form, bypassing the conversion steps required by folic acid.
Download our new scientific infographic.